[Prophylaxis of hemolytic disease of newborn].
D000022:Abortion, Spontaneous / Q000276:immunology; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D001805:Blood Transfusion, Intrauterine; D004899:Erythroblastosis, Fetal / Q000276:immunology / Q000517:prevention & control*; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006801:Humans; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D012737:Sex Factors; D013997:Time Factors
D000906:Antibodies; D012204:Rh-Hr Blood-Group System
Profilaktyka choroby hemolitycznej noworodków.